Danaher Corporation (DHR) PE Ratio: 35.52
Is Danaher Corporation’s P/E ratio high or low?
Danaher Corporation's P/E ratio of 35.52 is in line with its 5-year average of 34.94, around the middle of its 5-year range (21.56–51.93).
As of Thursday, June 11, 2026. 14.65% below its 12-month average of 41.61.
PE Ratio (35.52) = Close Price ($183.63) / Diluted TTM EPS ($5.17)
DHR PE Ratio Chart
DHR Average PE Ratio Chart
DHR Current vs Average PE Ratio Chart
DHR PE Ratio Metrics
PE RATIO
35.52
PE RATIO AVG TTM
41.61
PE RATIO AVG 3Y
38.62
PE RATIO AVG 5Y
34.94
PE RATIO AVG 10Y
31.96
PE RATIO AVG 15Y
25.62
PE RATIO AVG 20Y
22.45
CURRENT VS TTM AVG
-14.65%
CURRENT VS 3Y AVG
-8.03%
CURRENT VS 5Y AVG
+1.65%
CURRENT VS 10Y AVG
+11.13%
CURRENT VS 15Y AVG
+38.62%
CURRENT VS 20Y AVG
+58.25%
DHR Competitors' PE Ratio
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Danaher Corporation (DHR) | $126.39B | 35.52 | 41.61 | 38.62 | 34.94 |
| CVS Health Corporation (CVS) | $126.70B | 43.18 | 81.81 | 37.72 | 30.77 |
| Bristol-Myers Squibb Company (BMY) | $116.13B | 15.98 | 17.62 | 16.34 | 19.36 |
| Vertex Pharmaceuticals Incorporated (VRTX) | $110.59B | 26.09 | 29.53 | 29.27 | 27.23 |
| Intuitive Surgical, Inc. (ISRG) | $144.79B | 49.94 | 65.94 | 75.04 | 71.85 |
| Pfizer Inc. (PFE) | $149.61B | 20.06 | 16.37 | 22.39 | 18.18 |
| Medtronic plc (MDT) | $102.72B | 21.51 | 25.27 | 27.00 | 28.75 |
| Abbott Laboratories (ABT) | $155.75B | 24.94 | 19.33 | 27.88 | 28.19 |
| Gilead Sciences, Inc. (GILD) | $156.35B | 16.55 | 21.34 | 157.50 | 110.62 |
| Elevance Health Inc. (ELV) | $86.47B | 17.21 | 13.84 | 16.38 | 17.76 |
P/E vs. its own history
At 35.5, P/E is richer than usual, sitting higher than 80% of its 20-year history.
20-year low
8.2
median
16.0
20-year high
51.9
P/E Comparison
Trailing P/E
35.5
Forward P/E
20.2
Forward P/E Calculation
View All Analyst EstimatesForward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$183.63
Forward EPS (Est.)
$9.10
Forward P/E
20.18
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
Danaher Corporation PE Ratio Formula & Definition
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Danaher Corporation PE Ratio FAQ
- What is the P/E ratio for Danaher Corporation (DHR)?
- The P/E ratio for DHR stock is 35.52.
- Is Danaher Corporation's P/E ratio high or low?
- Danaher Corporation's P/E ratio of 35.52 is in line with its 5-year average of 34.94, around the middle of its 5-year range (21.56–51.93).
- What is the TTM average P/E ratio for Danaher Corporation (DHR)?
- The TTM average P/E ratio for DHR stock is 41.61.
- What is the 3Y average P/E ratio for Danaher Corporation (DHR)?
- The 3Y average P/E ratio for DHR stock is 38.62.
- What is the 5Y average P/E ratio for Danaher Corporation (DHR)?
- The 5Y average P/E ratio for DHR stock is 34.94.
- What is the 10Y average P/E ratio for Danaher Corporation (DHR)?
- The 10Y average P/E ratio for DHR stock is 31.96.
- What is the 15Y average P/E ratio for Danaher Corporation (DHR)?
- The 15Y average P/E ratio for DHR stock is 25.62.
- What is the 20Y average P/E ratio for Danaher Corporation (DHR)?
- The 20Y average P/E ratio for DHR stock is 22.45.
Danaher Corporation PE Ratio History
| DATE | PE RATIO |
|---|---|
| 2026-06-10 | 35.52 |
| 2026-06-09 | 36.44 |
| 2026-06-08 | 35.50 |
| 2026-06-05 | 35.65 |
| 2026-06-04 | 36.10 |
| 2026-06-03 | 34.44 |
| 2026-06-02 | 34.06 |
| 2026-06-01 | 34.79 |
| 2026-05-29 | 35.33 |
| 2026-05-28 | 34.94 |
| 2026-05-27 | 33.49 |
| 2026-05-26 | 33.43 |
| 2026-05-22 | 33.27 |
| 2026-05-21 | 33.53 |
| 2026-05-20 | 33.10 |
| 2026-05-19 | 32.31 |
| 2026-05-18 | 31.69 |
| 2026-05-15 | 31.32 |
| 2026-05-14 | 31.83 |
| 2026-05-13 | 32.11 |
| 2026-05-12 | 32.16 |
| 2026-05-11 | 32.21 |
| 2026-05-08 | 33.11 |
| 2026-05-07 | 33.98 |
| 2026-05-06 | 33.83 |
| 2026-05-05 | 33.78 |
| 2026-05-04 | 33.66 |
| 2026-05-01 | 33.88 |
| 2026-04-30 | 34.61 |
| 2026-04-29 | 34.58 |
| 2026-04-28 | 34.62 |
| 2026-04-27 | 34.94 |
| 2026-04-24 | 34.28 |
| 2026-04-23 | 34.54 |
| 2026-04-22 | 35.60 |
| 2026-04-21 | 37.63 |
| 2026-04-20 | 37.81 |
| 2026-04-17 | 38.64 |
| 2026-04-16 | 38.45 |
| 2026-04-15 | 39.31 |
| 2026-04-14 | 39.41 |
| 2026-04-13 | 38.86 |
| 2026-04-10 | 37.62 |
| 2026-04-09 | 38.29 |
| 2026-04-08 | 38.93 |
| 2026-04-07 | 37.90 |
| 2026-04-06 | 38.12 |
| 2026-04-02 | 37.92 |
| 2026-04-01 | 37.86 |
| 2026-03-31 | 37.62 |
| 2026-03-30 | 36.49 |
| 2026-03-27 | 36.02 |
| 2026-03-26 | 37.31 |
| 2026-03-25 | 37.13 |
| 2026-03-24 | 37.72 |
| 2026-03-23 | 37.70 |
| 2026-03-20 | 37.57 |
| 2026-03-19 | 37.72 |
| 2026-03-18 | 38.00 |
| 2026-03-17 | 38.73 |
| 2026-03-16 | 37.97 |
| 2026-03-13 | 37.17 |
| 2026-03-12 | 36.96 |
| 2026-03-11 | 38.70 |
| 2026-03-10 | 38.73 |
| 2026-03-09 | 39.44 |
| 2026-03-06 | 38.79 |
| 2026-03-05 | 40.08 |
| 2026-03-04 | 40.62 |
| 2026-03-03 | 40.48 |
| 2026-03-02 | 40.87 |
| 2026-02-27 | 41.79 |
| 2026-02-26 | 41.54 |
| 2026-02-25 | 41.57 |
| 2026-02-24 | 41.51 |
| 2026-02-23 | 43.49 |
| 2026-02-20 | 43.20 |
| 2026-02-19 | 43.56 |
| 2026-02-18 | 43.00 |
| 2026-02-17 | 42.55 |
| 2026-02-13 | 43.83 |
| 2026-02-12 | 44.32 |
| 2026-02-11 | 45.36 |
| 2026-02-10 | 45.31 |
| 2026-02-09 | 44.67 |
| 2026-02-06 | 44.66 |
| 2026-02-05 | 44.48 |
| 2026-02-04 | 45.26 |
| 2026-02-03 | 44.66 |
| 2026-02-02 | 46.07 |
| 2026-01-30 | 45.13 |
| 2026-01-29 | 45.28 |
| 2026-01-28 | 46.30 |
| 2026-01-27 | 48.61 |
| 2026-01-26 | 48.81 |
| 2026-01-23 | 48.46 |
| 2026-01-22 | 49.50 |
| 2026-01-21 | 49.91 |
| 2026-01-20 | 48.32 |
| 2026-01-16 | 48.66 |
| 2026-01-15 | 49.46 |
| 2026-01-14 | 49.06 |
| 2026-01-13 | 48.57 |
| 2026-01-12 | 49.28 |
| 2026-01-09 | 49.15 |
| 2026-01-08 | 48.45 |
| 2026-01-07 | 48.57 |
| 2026-01-06 | 48.78 |
| 2026-01-05 | 48.53 |
| 2026-01-02 | 47.51 |
| 2025-12-31 | 47.20 |
| 2025-12-30 | 47.56 |
| 2025-12-29 | 47.55 |
| 2025-12-26 | 47.49 |
| 2025-12-24 | 47.73 |
| 2025-12-23 | 47.59 |
| 2025-12-22 | 47.01 |
| 2025-12-19 | 46.36 |
| 2025-12-18 | 46.26 |
| 2025-12-17 | 45.90 |
| 2025-12-16 | 46.33 |
| 2025-12-15 | 47.12 |
| 2025-12-12 | 46.67 |
| 2025-12-11 | 47.91 |
| 2025-12-10 | 47.51 |
| 2025-12-09 | 46.03 |
| 2025-12-08 | 46.28 |
| 2025-12-05 | 46.65 |
| 2025-12-04 | 46.83 |
| 2025-12-03 | 47.11 |
| 2025-12-02 | 46.72 |
| 2025-12-01 | 46.21 |
| 2025-11-28 | 46.76 |
| 2025-11-26 | 47.11 |
| 2025-11-25 | 47.58 |
| 2025-11-24 | 46.80 |
| 2025-11-21 | 46.88 |
| 2025-11-20 | 45.81 |
| 2025-11-19 | 45.86 |
| 2025-11-18 | 46.50 |
| 2025-11-17 | 45.45 |
| 2025-11-14 | 45.61 |
| 2025-11-13 | 45.61 |
| 2025-11-12 | 45.24 |
| 2025-11-11 | 44.49 |
| 2025-11-10 | 43.54 |
| 2025-11-07 | 43.29 |
| 2025-11-06 | 43.44 |
| 2025-11-05 | 43.75 |
| 2025-11-04 | 44.09 |
| 2025-11-03 | 44.14 |
| 2025-10-31 | 44.41 |
| 2025-10-30 | 44.34 |
| 2025-10-29 | 44.13 |
| 2025-10-28 | 44.72 |
| 2025-10-27 | 45.57 |
| 2025-10-24 | 45.98 |
| 2025-10-23 | 45.92 |
| 2025-10-22 | 44.97 |
| 2025-10-21 | 45.52 |
| 2025-10-20 | 42.97 |
| 2025-10-17 | 44.48 |
| 2025-10-16 | 44.88 |
| 2025-10-15 | 43.85 |
| 2025-10-14 | 43.86 |
| 2025-10-13 | 43.65 |
| 2025-10-10 | 43.08 |
| 2025-10-09 | 43.51 |
| 2025-10-08 | 43.61 |
| 2025-10-07 | 44.42 |
| 2025-10-06 | 45.04 |
| 2025-10-03 | 45.74 |
| 2025-10-02 | 44.75 |
| 2025-10-01 | 45.29 |
| 2025-09-30 | 42.18 |
| 2025-09-29 | 39.59 |
| 2025-09-26 | 39.33 |
| 2025-09-25 | 38.61 |
| 2025-09-24 | 39.56 |
| 2025-09-23 | 40.37 |
| 2025-09-22 | 40.52 |
| 2025-09-19 | 41.13 |
| 2025-09-18 | 41.55 |
| 2025-09-17 | 41.05 |
| 2025-09-16 | 40.53 |
| 2025-09-15 | 40.11 |
| 2025-09-12 | 40.44 |
| 2025-09-11 | 41.52 |
| 2025-09-10 | 40.98 |
| 2025-09-09 | 41.35 |
| 2025-09-08 | 42.26 |
| 2025-09-05 | 42.60 |
| 2025-09-04 | 42.35 |
| 2025-09-03 | 42.43 |
| 2025-09-02 | 43.36 |
| 2025-08-29 | 43.79 |
| 2025-08-28 | 43.68 |
| 2025-08-27 | 43.62 |
| 2025-08-26 | 43.88 |
| 2025-08-25 | 44.20 |
| 2025-08-22 | 45.06 |
| 2025-08-21 | 43.38 |
| 2025-08-20 | 44.98 |
| 2025-08-19 | 45.15 |
| 2025-08-18 | 44.47 |
| 2025-08-15 | 44.88 |
| 2025-08-14 | 44.73 |
| 2025-08-13 | 44.50 |
| 2025-08-12 | 43.77 |
| 2025-08-11 | 42.50 |
| 2025-08-08 | 42.67 |
| 2025-08-07 | 42.23 |
| 2025-08-06 | 41.53 |
| 2025-08-05 | 42.35 |
| 2025-08-04 | 42.01 |
| 2025-08-01 | 41.93 |
| 2025-07-31 | 41.95 |
| 2025-07-30 | 43.40 |
| 2025-07-29 | 44.01 |
| 2025-07-28 | 43.18 |
| 2025-07-25 | 43.72 |
| 2025-07-24 | 43.15 |
| 2025-07-23 | 42.10 |
| 2025-07-22 | 40.41 |
| 2025-07-21 | 40.01 |
| 2025-07-18 | 36.90 |
| 2025-07-17 | 37.82 |
| 2025-07-16 | 37.53 |
| 2025-07-15 | 37.45 |
| 2025-07-14 | 38.40 |
| 2025-07-11 | 39.78 |
| 2025-07-10 | 39.90 |
| 2025-07-09 | 39.02 |
| 2025-07-08 | 38.97 |
| 2025-07-07 | 38.76 |
| 2025-07-03 | 39.46 |
| 2025-07-02 | 39.32 |
| 2025-07-01 | 39.05 |
| 2025-06-30 | 38.36 |
| 2025-06-27 | 38.60 |
| 2025-06-26 | 39.12 |
| 2025-06-25 | 39.03 |
| 2025-06-24 | 38.34 |
| 2025-06-23 | 38.12 |
| 2025-06-20 | 38.13 |
| 2025-06-18 | 37.76 |
| 2025-06-17 | 38.01 |
| 2025-06-16 | 39.05 |
| 2025-06-13 | 38.97 |
| 2025-06-12 | 39.83 |
| 2025-06-11 | 39.75 |
| 2025-06-10 | 39.34 |
| 2025-06-09 | 38.68 |
| 2025-06-06 | 38.06 |
| 2025-06-05 | 37.31 |
| 2025-06-04 | 37.49 |
| 2025-06-03 | 37.29 |
| 2025-06-02 | 36.74 |
| 2025-05-30 | 36.87 |
| 2025-05-29 | 36.98 |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Danaher Corporation
Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Rainer Blair